Aptalis Pharmaceutical Technologies Sponsors 2012 Controlled Release Society’s Young Investigator Award at Annual Meeting and Exposition
Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that focuses on developing differentiated oral products utilizing its pharmaceutical technologies, today announces its co-sponsorship of Controlled Release Society’s Young Investigator Award and its participation in the 39th Annual Meeting & Exposition of the Controlled Release Society July 15 – 18, 2012 in Québec City, Canada.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.